Full Text (PDF)
Original Article

Evolution in Medicinal Chemistry of Prazolopyrimidine Derivatives as Anticancer Agents

Asif Husain , Azhar Iqbal1 , Asif Husain2 , Mohammad Rashid3 , Mohammad Taha Kazmi4 , Aftab Ahmad5 , Khursheed A. Ansari6

Author Information

Licence:




Journal of Pharmaceutical and Medicinal Chemistry 5(1):p 27-39, January-June 2019. | DOI: DOI: http://dx.doi.org/10.21088/jpmc.2395.6615.5119.4

How Cite This Article:

Azhar Iqbal, Asif Husain, Mohammad Rashid et al. Evolution in Medicinal Chemistry of Prazolopyrimidine Derivatives as Anticancer Agents. J Pharmaceut Med Chem. 2019;5(1):27-39.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Pyrazolopyrimidines are the fused heterocyclic ring systems which structurally resemble with purines, and exhibit important biological actions. Pyrazolopyrimidines derivatives have great importance in the field of chemical synthesis, agriculture and pharmaceutical industries due to their wide range of applications. Over the past few decades, researchers have focused their research on the synthesis of novel pyrazolopyrimidine derivatives. The pyrazolopyrimidines heterocyclic ring is an integral part of various synthetic compounds with wide range of therapeutic and pharmacological potentials like anti-inflammatory, antibacterial, anticancer, antifungal, antiviral, anticonvulsant, anti-tubercular, etc Many marketed drugs are pyrazolopyrimidine derivatives like antiviral drugs which include acyclovir, ganciclovir, didanosine, abacavir and adefovir. Due to the wide scope of pharmacological potentials of pyrazolopyrimidine derivatives, research community has shown great interest to discover new pyrazolopyrimidines having potent bioactivities with no or lesser side effects. This review summarizes the recent developments on the synthetic approaches, mechanism of action and anticancer activity of pyrazolopyrimidines.

Keywords: Pyrazolopyrimidines, Anticancer


References

No records found.


About this article


Cite this article

Azhar Iqbal, Asif Husain, Mohammad Rashid et al. Evolution in Medicinal Chemistry of Prazolopyrimidine Derivatives as Anticancer Agents. J Pharmaceut Med Chem. 2019;5(1):27-39.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/jpmc.2395.6615.5119.4

Keywords


Article Level Metrics

Last Updated

Monday 07 September 2026, 23:49:26 (IST)


1018

Accesses

5
100
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share